Conference Coverage
Conference Coverage
Evolocumab safe and effective in pediatric FH
The PCSK9 inhibitor lowered LDL cholesterol by 38% vs placebo in HAUSER-RCT, the first randomized controlled trial of one of these agents in the...
Conference Coverage
ATPCI: Trimetazidine fizzles for post-PCI angina
The antianginal was unable to provide added benefit when added to optimal medical therapy, but one expert questions: Was the right population...
Conference Coverage
DAPA-CKD: SGLT2 inhibitor benefit extends to chronic kidney disease without diabetes
DAPA-CKD showed that dapagliflozin helps patients with albuminuria and declining eGFR levels whether or not they have type 2 diabetes.
Conference Coverage
RATE-AF trial boosts digoxin for rate control in permanent AFib
Study shows equally good rate control as with a beta-blocker, but with far fewer adverse events.
Conference Coverage
New ESC/EACTS guideline on atrial fibrillation
The document takes a paradigm shift away from the conventional classification of AFib and goes all in on measuring quality of care, including...
Conference Coverage
EXPLORER trial hints at potential new drug option in obstructive hypertrophic cardiomyopathy
Mavacamten, which seemed to improve function and alleviate symptoms in the short trial, is the first potential drug for the disorder that...
Conference Coverage
EMPEROR-Reduced: Empagliflozin’s HFrEF benefit solidifies class effects
Conference Coverage
Early rhythm control in AFib gains new life
EAST-AFNET 4 trial reanimates rhythm-control strategy as superior for 5-year cardiovascular outcomes.
Conference Coverage
COVID-19 vaccine supply will be limited at first, ACIP says
The working group expects that from 15 to 45 million doses of vaccine will be available by the end of December, depending on which vaccine is...
Conference Coverage
ESC 2020 looks to make its mark in ‘new era’ of virtual meetings
COVID-19 prompted the Netherlands to close the door on large public gatherings, forcing organizers to look for a digital window to deliver the...
Conference Coverage
CT-FFR offers a noninvasive ‘one-stop shop’ for pre-TAVR assessment
The novel technology, coronary CT angiography–derived fractional flow reserve, speeds the TAVR patient’s diagnostic journey.